Candriam Equities L Oncology Impact PI/ LU1864483836 /
| NAV06/06/2024 | Chg.+9.0300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,567.2300USD | +0.35% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | - | 2.70 | -3.61 | -2.53 | 8.73 | 0.34 | -0.24 | -3.14 | 5.14 | 8.00 | 5.07 | - |
| 2020 | -1.43 | -5.31 | -3.03 | 12.16 | 8.58 | 1.46 | 4.47 | 2.19 | 3.55 | -2.17 | 5.86 | 3.90 | +33.03% |
| 2021 | 0.58 | -4.17 | -0.05 | 2.37 | 0.21 | 3.57 | -0.93 | 5.62 | -3.73 | 3.41 | -6.33 | 4.03 | +3.90% |
| 2022 | -10.46 | -1.72 | 4.69 | -5.82 | -1.29 | 0.08 | 4.40 | -3.10 | -4.68 | 7.08 | 6.11 | -3.41 | -9.27% |
| 2023 | 2.20 | -3.85 | 1.42 | 2.86 | -2.52 | 0.12 | 0.93 | -1.98 | -5.21 | -6.32 | 9.26 | 5.77 | +1.56% |
| 2024 | 1.41 | 4.18 | 1.53 | -3.34 | 2.52 | 2.52 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.70% | 10.96% | 11.68% | 14.66% | 17.20% |
| Sharpe ratio | 1.73 | 2.47 | 0.39 | -0.14 | 0.43 |
| Best month | +5.77% | +5.77% | +9.26% | +9.26% | +12.16% |
| Worst month | -3.34% | -3.34% | -6.32% | -10.46% | -10.46% |
| Maximum loss | -6.73% | -6.73% | -15.24% | -24.42% | -24.42% |
| Outperformance | +16.58% | - | +23.21% | - | - |
All quotes in USD
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,402.3501 | +8.18% | +4.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,567.2300 | +8.32% | +5.38% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.7400 | +4.62% | -5.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,235.0200 | +4.75% | +15.35% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.9800 | +7.83% | +3.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.2300 | +4.97% | +13.24% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2600 | +6.82% | +1.10% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3900 | +7.73% | +3.67% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,691.0000 | +2.80% | +0.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.1100 | +4.63% | +14.96% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,113.1299 | +5.61% | -3.17% | |
| Candriam Equities L Oncology Imp... | reinvestment | 259.9500 | +5.87% | +16.14% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.1800 | +4.19% | -6.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.9900 | +7.72% | +3.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.0700 | +5.49% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,843.8000 | +5.09% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,875.2300 | +7.38% | +3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.6200 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 273.5400 | +6.37% | +0.73% |
Performance
| YTD | +8.96% | ||
|---|---|---|---|
| 6 Months | +14.33% | ||
| 1 Year | +8.32% | ||
| 3 Years | +5.38% | ||
| 5 Years | +69.87% | ||
| 10 Years | - | ||
| Since start | +70.39% | ||
| Year | |||
| 2023 | +1.56% | ||
| 2022 | -9.27% | ||
| 2021 | +3.90% | ||
| 2020 | +33.03% | ||
